GH

Gururaj Hejamady Tati Rao

Active Director Designated Partner DIN 01405465
DIN 01405465 First appointment Nov 2004 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 4 historical roles
Total affiliations 7 Since Nov 2004
Shareholding value •••• Premium profile

About Gururaj Hejamady Tati Rao

Data last updated:

Gururaj Hejamady Tati Rao is a Designated Partner at Gururajgovind Lifesciences Yelahanka Llp (since 2018), Director at Bhima Diagnostics Private Limited (since 2023) and Designated Partner at Bhima Lifesciences Llp (since 2016). The companies operate in Healthcare. The largest current company by reported revenue is Gururajgovind Lifesciences Yelahanka Llp at ₹9.20 Cr (FY 2021). Earlier, Gururaj Hejamady Tati Rao was a Nominee Director at Total X-Ray And Lab Solutions Private Limited (2019–2023) and Director at Clumax Diagnostic And Research Centre Private Limited (2004–2012) and 2 more.

DIN 01405465
Primary Designation Designated Partner
Industry Healthcare
First Appointment 24 Nov 2004
Oldest Company Age 10 yrs
Largest company Gururajgovind Lifesciences Yelahanka Llp · ₹9.20 Cr (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner08 Jan 20182018₹9.20 Cr (FY 2021)Active
Bhima Diagnostics Private Limited U86905KA2023PTC176828
Director01 Aug 20232023Active
Designated Partner19 Jul 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director09 May 20192016₹8.26 Cr (FY 2024)Active
Director24 Nov 20042004₹18.78 Cr (FY 2024)Active
Director14 Feb 20092008Under Liquidation
Designated Partner31 Oct 20172017Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Gururaj Hejamady Tati Rao

Directorship timeline

Open interactive timeline →
Bhima Lifesciences Llp
Gururajgovind Lifesciences Yelahanka Llp
Bhima Diagnostics Private Limited
Total X-Ray And Lab Solutions Private Limited
Premium access

Shareholding and investment profile for Gururaj Hejamady Tati Rao

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gururaj Hejamady Tati Rao

Gururaj Hejamady Tati Rao currently holds 3 directorships: Gururajgovind Lifesciences Yelahanka Llp (Designated Partner, since 08 Jan 2018, revenue ₹9.20 Cr (FY 2021)); Bhima Diagnostics Private Limited (Director, since 01 Aug 2023); Bhima Lifesciences Llp (Designated Partner, since 19 Jul 2016).

Gururaj Hejamady Tati Rao was first appointed on 24 Nov 2004 as Director at Clumax Diagnostic And Research Centre Private Limited. The most recent appointment on record is 01 Aug 2023 at Bhima Diagnostics Private Limited.

Gururaj Hejamady Tati Rao held 4 earlier board appointments: Total X-Ray And Lab Solutions Private Limited (Nominee Director, 09 May 2019 to 22 Sep 2023); Clumax Diagnostic And Research Centre Private Limited (Director, 24 Nov 2004 to 14 Feb 2012); Anca Healthservices And Research Centre Private Limited (Director, 14 Feb 2009 to 16 Aug 2011); Gururajgovind Lifesciences Whitefield Llp (Designated Partner, 31 Oct 2017 to 01 Jul 2021).

The current boards of Gururaj Hejamady Tati Rao's companies include Arathy Govindan (Gururajgovind Lifesciences Yelahanka Llp), Dasanna Umashankar (Gururajgovind Lifesciences Yelahanka Llp), Bhima Bhatter Govindan (Bhima Lifesciences Llp), Jayalakshmi Govindan (Bhima Lifesciences Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available